Severe sinus bradycardia associated with favipiravir in a COVID-19 patient

Clin Case Rep. 2021 Aug 6;9(8):e04566. doi: 10.1002/ccr3.4566. eCollection 2021 Aug.

Authors

Mhd Baraa Habib¹, Mohamed Elshafei², Alaa Rahhal², Mouhand F H Mohamed¹

Affiliations

¹ Department of Internal Medicine Hamad Medical Corporation Doha Qatar.
² Department of Pharmacy Hamad Medical Corporation Doha Qatar.

Abstract

The antiviral medication "favipiravir" should be considered as a possible cause of unexplained sinus bradycardia.

Keywords: drug‐associated; favipiravir; severe bradycardia; sinus rhythm.

© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Publication types

Case Reports